Ensaid Tablets (Talniflumate)

Adult dose

Administer talniflumate 370 mg orally per dose, 3 times daily. For severe cases, administer 740 mg per dose. Adjust the dose appropriately according to age and symptoms.

This medication may cause gastrointestinal bleeding in individuals who regularly consume more than three alcoholic drinks a day, so it is essential to consult a doctor or pharmacist. This medication may affect the cardiovascular system and increase the risk of serious cardiovascular diseases such as myocardial infarction or stroke. Patients with a history of cardiovascular diseases or risk factors must exercise extra caution and consult medical personnel immediately if symptoms occur. This medication may cause severe gastrointestinal adverse reactions, such as gastrointestinal bleeding, ulcers, or perforations, so patients should be alert for gastrointestinal symptoms while taking it, particularly the elderly or those with a history of gastrointestinal disorders. Patients with a history of peptic ulcer disease or allergies to this medication or its components, as well as those who have hypersensitivity to aspirin or other non-steroidal anti-inflammatory drugs, should not use this medication. Patients with severely impaired liver or kidney function, pregnant women, or women who may become pregnant should also avoid taking this medication for safety. In cases of mild liver or kidney impairment, elderly, or individuals allergic to certain dye components, this medication should be used with caution. During use, gastrointestinal symptoms such as nausea, vomiting, diarrhea, abdominal pain, or allergic reactions like skin rashes, itching, and hives may occur; any unusual symptoms should be reported to the healthcare provider immediately. This medication may cause cardiovascular side effects such as elevated blood pressure, cardiac arrhythmias, or edema; careful monitoring is required if these symptoms occur. Long-term use requires regular monitoring of liver and kidney functions, and if any abnormal signs appear, the medication should be adjusted or discontinued. Interactions may occur when taken with other anti-inflammatory pain relievers, certain antihypertensive drugs, diuretics, anticoagulants, etc.; therefore, if other medications are being taken, consultation with a doctor or pharmacist is essential. Pregnant women, especially in the late stages of pregnancy, should not take this medication as it may be harmful to the fetus, and breastfeeding mothers are advised to either stop breastfeeding or discontinue the medication. This medication is not for use in children under 12 years old, and the elderly should be administered the minimum dose with special attention to adverse reactions. This medication should be kept out of reach of children, and transferring it to other containers is not advisable for maintaining quality.

• nausea
• vomiting
• photosensitivity
• asthma attack
• hypotension
• general malaise
• hypersensitivity shock
• diarrhea
• abdominal distension
• constipation

This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained between 1°C and 30°C at room temperature, avoiding excessively hot or cold areas.

Appearance

Yellow film-coated round tablets

Package unit

30 tablets per bottle, 300 tablets per bottle